相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Monitoring and adapting cancer treatment using circulating tumor DNA kinetics: Current research, opportunities, and challenges
Enrique Sanz-Garcia et al.
SCIENCE ADVANCES (2022)
ESMO recommendations on the use of circulating tumour DNA assays for patients with cancer: a report from the ESMO Precision Medicine Working Group
J. Pascual et al.
ANNALS OF ONCOLOGY (2022)
Circulating tumor DNA: current challenges for clinical utility
Donna K. Dang et al.
JOURNAL OF CLINICAL INVESTIGATION (2022)
Current and future challenges in quality assurance in molecular diagnostics
Parviz Ahmad-Nejad et al.
CLINICA CHIMICA ACTA (2021)
Longitudinal Relationship between Idylla Plasma ctBRAF V600 Mutation Detection and Tumor Burden in Patients with Metastatic Melanoma
Mark William Linder et al.
MOLECULAR DIAGNOSIS & THERAPY (2021)
Liquid Biopsy: From Discovery to Clinical Application
Catherine Alix-Panabieres et al.
CANCER DISCOVERY (2021)
The molecular profiling of solid tumors by liquid biopsy: a position paper of the AIOM-SIAPEC-IAP-SIBioC-SIC-SIF itallan Scientific Societies
A. Russo et al.
ESMO OPEN (2021)
Molecular and Functional Characterization of Circulating Tumor Cells: From Discovery to Clinical Application
Luis Enrique Cortes-Hernandez et al.
CLINICAL CHEMISTRY (2020)
Preanalytical variables that affect the outcome of cell-free DNA measurements
Vida Ungerer et al.
CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES (2020)
Putative Origins of Cell-Free DNA in Humans: A Review of Active and Passive Nucleic Acid Release Mechanisms
Stefan Grabuschnig et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Are tumor size changes predictive of survival for checkpoint blockade based immunotherapy in metastatic melanoma?
Meihua Wang et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
Cell-free DNA diagnostics: current and emerging applications in oncology
Penn Muluhngwi et al.
PHARMACOGENOMICS (2019)
Circulating biomarkers for early detection and clinical management of colorectal cancer
Maria Marcuello et al.
MOLECULAR ASPECTS OF MEDICINE (2019)
Results of the first external quality assessment scheme (EQA) for isolation and analysis of circulating tumour DNA (ctDNA)
Verena Haselmann et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2018)
Circulating Tumor DNA Analysis in Patients With Cancer: American Society of Clinical Oncology and College of American Pathologists Joint Review
Jason D. Merker et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Phylogenetic ctDNA analysis depicts early-stage lung cancer evolution
Christopher Abbosh et al.
NATURE (2017)
Liquid Biopsies in Oncology and the Current Regulatory Landscape
Lindsay N. Strotman et al.
MOLECULAR DIAGNOSIS & THERAPY (2016)
Clinical Applications of Circulating Tumor Cells and Circulating Tumor DNA as Liquid Biopsy
Catherine Alix-Panabieres et al.
CANCER DISCOVERY (2016)
Circulating Tumor DNA as a Liquid Biopsy for Cancer
Ellen Heitzer et al.
CLINICAL CHEMISTRY (2015)
Spatial and temporal diversity in genomic instability processes defines lung cancer evolution
Elza C. de Bruin et al.
SCIENCE (2014)
Detection and quantification of rare mutations with massively parallel sequencing
Isaac Kinde et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Changes in concentration of DNA in serum and plasma during storage of blood samples
M Jung et al.
CLINICAL CHEMISTRY (2003)